Characterization of a novel chimeric theileria parva p67 antigen which incorporates into virus-like particles and is highly immunogenic in mice

HIGHLIGHTS

• who: Leah Whittle et al. from the Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa have published the paper: Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice, in the Journal: Vaccines 2022, 10, 210. of 16/Dec/2021
• what: The authors show that it is possible to integrate a form of p67 containing all known antigenic domains VLPs. The authors show that BLV Gag VLPs can be used for heterologous antigen display. The authors show . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.